Causes of death among people living with metastatic cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Most metastatic cancer patients die from their cancer, but some succumb to other causes like heart disease. Risk varies by cancer type, with lung and pancreas cancers posing higher mortality risks.
Area Of Science
- Oncology
- Epidemiology
- Biostatistics
Background
- Understanding mortality in metastatic cancer is crucial for patient care and resource allocation.
- Competing causes of death significantly impact survival statistics for cancer patients.
Purpose Of The Study
- To analyze causes of death in a large cohort of metastatic cancer patients.
- To identify cancer types with higher mortality risk from the primary cancer versus competing causes.
- To predict the risk of death from diagnosed cancer versus other causes.
Main Methods
- Analysis of a large US dataset (1992-2019) of over 1 million metastatic cancer survivors.
- Characterization of causes of death across 13 cancer types and 25 non-cancer conditions.
- Application of the Fine and Gray competing risk model to predict survival.
Main Results
- 82.6% of patients died from their diagnosed metastatic cancer; 17.4% died from competing causes.
- Lung, pancreas, esophagus, and stomach cancers had the highest likelihood of death from cancer.
- Prostate and breast cancers had the lowest likelihood of death from cancer.
- Leading non-cancer causes of death included heart disease (32.4%), COPD (7.9%), and stroke (6.1%).
Conclusions
- While diagnosed cancer is the primary cause of death in most metastatic patients, competing causes are significant.
- Cancer type strongly influences the likelihood of dying from the primary disease versus other conditions.
- Accurate risk prediction models are essential for understanding and managing mortality in advanced cancer.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumors may result in a case where two people have the same mutations in an oncogene or tumor...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...